Suramin (Antrypol)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 17:46, 20 December 2021 by Jwarner (talk | contribs) (Created page with "==Mechanism of action== Antiparasitic with mechanism of action unclear. ==Diseases for which it was used== *Prostate cancer ==History of changes in FDA indication== *Thi...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Mechanism of action

Antiparasitic with mechanism of action unclear.

Diseases for which it was used

History of changes in FDA indication

  • This drug is not FDA approved. Of note, it was investigated in prostate cancer but utility was not proven and investigations have been discontinued.
Retrieved from "https://hemonc.org/w/index.php?title=Suramin_(Antrypol)&oldid=53960"